Rapid Detection with New Trichomonas Monoclonal Antibodies

5 Nov 2010
Sarah Sarah
Marketing / Sales

Product news

ViroStat introduces a set of new monoclonal antibodies for Trichomonas vaginalis and Trichomonas foetus which may aid in their rapid detection. Validated applications of these antibodies include immunoflourescence staining, ELISA and lateral flow.

Trichomonas vaginalis is a common human pathogen of the male and female urogenital tract leading to vaginitis and urethritis. Its high prevalence in carriers is associated with adverse outcomes during pregnancy. Diagnosis of this parasite commonly involves visual examination of microscopic smears (wet mount). More recently culture methods have been introduced. However, these can take several days for a result.

Trichomonas foetus likewise is a sexually transmitted pathogen of several animal species including cattle and cats and leads to reproductive failure in these animals.

Tags

AntibodiesAntibodies are used in techniques such as confocal and fluorescence microscopy, flow cytometry, ELISA, ELISPOT, immunohistochemistry, western blotting and immunopreciptation. Select specific antigen reactivity, high specific affinity, low non-specific binding, monoclonal or polyclonal, primary or secondary antibodies and associated conjugates such as an enzyme or dye for visualization.Point-of-CarePoint-of-Care Testing (POCT) or Near Patient Testing (NPT) products are available for urine, blood and other clinical chemistry analyses. POCT includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing (PT / INR), rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.